Among the 14 genes in our cohort, except for PIK3CA (6.3% vs. 12.0%) and FGFR1 (1.98% vs. no data), the prevalence of the other 12 genes was similar to the results reported in a previous Chinese NSCLC population.11 This evidence concerns the gene FGFR1 and non-small cell lung carcinoma.